{
    "address1": "777 Old Saw Mill River Road",
    "city": "Tarrytown",
    "state": "NY",
    "zip": "10591-6707",
    "country": "United States",
    "phone": "914 847 7000",
    "website": "https://www.regeneron.com",
    "industry": "Biotechnology",
    "industryDisp": "Biotechnology",
    "sector": "Healthcare",
    "sectorDisp": "Healthcare",
    "longBusinessSummary": "Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat neovascular age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; diabetic retinopathy; neovascular glaucoma; and retinopathy of prematurity. It also provides Dupixent injection to treat atopic dermatitis and asthma in adults and pediatrics; Libtayo injection to treat metastatic or locally advanced cutaneous squamous cell carcinoma; Praluent injection for heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease in adults; REGEN-COV for covid-19; and Kevzara solution for treating rheumatoid arthritis in adults. In addition, the company offers Inmazeb injection for infection caused by Zaire ebolavirus; ARCALYST injection for cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and muckle-wells syndrome; and ZALTRAP injection for intravenous infusion to treat metastatic colorectal cancer; and develops product candidates for treating patients with eye, allergic and inflammatory, cardiovascular and metabolic, infectious, and rare diseases; and cancer, pain, and hematologic conditions. It has collaboration and license agreements with Sanofi; Bayer; Teva Pharmaceutical Industries Ltd.; Mitsubishi Tanabe Pharma Corporation; Alnylam Pharmaceuticals, Inc.; Roche Pharmaceuticals; and Kiniksa Pharmaceuticals, Ltd., as well as has an agreement with the U.S. Department of Health and Human Services, as well as with Zai Lab Limited; Intellia Therapeutics, Inc.; Biomedical Advanced Research Development Authority; and AstraZeneca PLC. The company was incorporated in 1988 and is headquartered in Tarrytown, New York.",
    "fullTimeEmployees": 12256,
    "companyOfficers": [
        {
            "maxAge": 1,
            "name": "Dr. Leonard S. Schleifer M.D., Ph.D.",
            "age": 69,
            "title": "Co-Founder, Pres, CEO & Co-Chairman",
            "yearBorn": 1953,
            "fiscalYear": 2022,
            "totalPay": 7004069,
            "exercisedValue": 0,
            "unexercisedValue": 256815824
        },
        {
            "maxAge": 1,
            "name": "Dr. George D. Yancopoulos M.D., Ph.D.",
            "age": 62,
            "title": "Co-Founder, Pres, Chief Scientific Officer & Co-Chairman",
            "yearBorn": 1960,
            "fiscalYear": 2022,
            "totalPay": 6593696,
            "exercisedValue": 0,
            "unexercisedValue": 242710064
        },
        {
            "maxAge": 1,
            "name": "Mr. Robert E. Landry Jr.",
            "age": 58,
            "title": "Exec. VP of Fin. & CFO",
            "yearBorn": 1964,
            "fiscalYear": 2022,
            "totalPay": 1839460,
            "exercisedValue": 11097488,
            "unexercisedValue": 25114408
        },
        {
            "maxAge": 1,
            "name": "Dr. Andrew J. Murphy Ph.D.",
            "age": 63,
            "title": "Exec. VP of Research",
            "yearBorn": 1959,
            "fiscalYear": 2022,
            "totalPay": 1622950,
            "exercisedValue": 19388300,
            "unexercisedValue": 83458888
        },
        {
            "maxAge": 1,
            "name": "Mr. Daniel P. Van Plew",
            "age": 49,
            "title": "Exec. VP and GM of Industrial Operations & Product Supply",
            "yearBorn": 1973,
            "fiscalYear": 2022,
            "totalPay": 1954399,
            "exercisedValue": 45282380,
            "unexercisedValue": 24788798
        },
        {
            "maxAge": 1,
            "name": "Ms. Marion E. McCourt",
            "age": 62,
            "title": "Exec. VP of Commercial",
            "yearBorn": 1960,
            "fiscalYear": 2022,
            "totalPay": 1500262,
            "exercisedValue": 4246309,
            "unexercisedValue": 8790830
        },
        {
            "maxAge": 1,
            "name": "Ms. Patrice  Gilooly",
            "title": "Sr. VP of Quality Assurance & Operations",
            "exercisedValue": 0,
            "unexercisedValue": 0
        },
        {
            "maxAge": 1,
            "name": "Mr. Christopher R. Fenimore",
            "age": 51,
            "title": "Sr. VP, Head of Accounting & Controller",
            "yearBorn": 1971,
            "exercisedValue": 0,
            "unexercisedValue": 0
        },
        {
            "maxAge": 1,
            "name": "Mr. Gerald  Underwood",
            "title": "Sr. VP of Technical Operations",
            "exercisedValue": 0,
            "unexercisedValue": 0
        },
        {
            "maxAge": 1,
            "name": "Mr. Bob  McCowan",
            "title": "Sr. VP of IT & Chief Information Officer",
            "exercisedValue": 0,
            "unexercisedValue": 0
        }
    ],
    "auditRisk": 9,
    "boardRisk": 10,
    "compensationRisk": 9,
    "shareHolderRightsRisk": 10,
    "overallRisk": 10,
    "governanceEpochDate": 1693526400,
    "compensationAsOfEpochDate": 1672444800,
    "maxAge": 86400,
    "priceHint": 2,
    "previousClose": 825.26,
    "open": 830.36,
    "dayLow": 825.3,
    "dayHigh": 841.16,
    "regularMarketPreviousClose": 825.26,
    "regularMarketOpen": 830.36,
    "regularMarketDayLow": 825.3,
    "regularMarketDayHigh": 841.16,
    "payoutRatio": 0.0,
    "beta": 0.185684,
    "trailingPE": 21.831537,
    "forwardPE": 19.171244,
    "volume": 421650,
    "regularMarketVolume": 421650,
    "averageVolume": 612609,
    "averageVolume10days": 356350,
    "averageDailyVolume10Day": 356350,
    "bid": 0.0,
    "ask": 0.0,
    "bidSize": 800,
    "askSize": 3200,
    "marketCap": 90178879488,
    "fiftyTwoWeekLow": 668.0,
    "fiftyTwoWeekHigh": 847.5,
    "priceToSalesTrailing12Months": 7.117063,
    "fiftyDayAverage": 769.8594,
    "twoHundredDayAverage": 761.7072,
    "trailingAnnualDividendRate": 0.0,
    "trailingAnnualDividendYield": 0.0,
    "currency": "USD",
    "enterpriseValue": 81793343488,
    "profitMargins": 0.33928,
    "floatShares": 101359050,
    "sharesOutstanding": 106741000,
    "sharesShort": 1360156,
    "sharesShortPriorMonth": 1268810,
    "sharesShortPreviousMonthDate": 1689292800,
    "dateShortInterest": 1692057600,
    "sharesPercentSharesOut": 0.0125,
    "heldPercentInsiders": 0.02542,
    "heldPercentInstitutions": 0.89447,
    "shortRatio": 2.31,
    "shortPercentOfFloat": 0.0149,
    "impliedSharesOutstanding": 108559000,
    "bookValue": 225.944,
    "priceToBook": 3.6765304,
    "lastFiscalYearEnd": 1672444800,
    "nextFiscalYearEnd": 1703980800,
    "mostRecentQuarter": 1688083200,
    "earningsQuarterlyGrowth": 0.136,
    "netIncomeToCommon": 4298999808,
    "trailingEps": 38.05,
    "forwardEps": 43.33,
    "pegRatio": 4.2,
    "enterpriseToRevenue": 6.455,
    "enterpriseToEbitda": 16.987,
    "52WeekChange": 0.16876781,
    "SandP52WeekChange": 0.08443928,
    "exchange": "NMS",
    "quoteType": "EQUITY",
    "symbol": "REGN",
    "underlyingSymbol": "REGN",
    "shortName": "Regeneron Pharmaceuticals, Inc.",
    "longName": "Regeneron Pharmaceuticals, Inc.",
    "firstTradeDateEpochUtc": 670602600,
    "timeZoneFullName": "America/New_York",
    "timeZoneShortName": "EDT",
    "uuid": "e55aa808-7510-354a-9528-01782e66194d",
    "messageBoardId": "finmb_33715",
    "gmtOffSetMilliseconds": -14400000,
    "currentPrice": 830.69,
    "targetHighPrice": 1050.0,
    "targetLowPrice": 665.0,
    "targetMeanPrice": 898.86,
    "targetMedianPrice": 890.0,
    "recommendationMean": 2.1,
    "recommendationKey": "buy",
    "numberOfAnalystOpinions": 22,
    "totalCash": 8927699968,
    "totalCashPerShare": 84.256,
    "ebitda": 4815099904,
    "totalDebt": 2702200064,
    "quickRatio": 4.526,
    "currentRatio": 5.451,
    "totalRevenue": 12670799872,
    "debtToEquity": 11.251,
    "revenuePerShare": 118.474,
    "returnOnAssets": 0.09548,
    "returnOnEquity": 0.19232,
    "grossProfits": 7020000000,
    "freeCashflow": 2257374976,
    "operatingCashflow": 4738800128,
    "earningsGrowth": 0.138,
    "revenueGrowth": 0.105,
    "grossMargins": 0.53739,
    "ebitdaMargins": 0.38002,
    "operatingMargins": 0.34882,
    "financialCurrency": "USD",
    "trailingPegRatio": 1.7635,
    "parent_etfs": [
        "AGNG"
    ]
}